Psychological distress during the Covid-19 pandemic : an analysis of antipsychotic drug usage patterns in a sample of Italian residents.
INTRODUCTION: The ongoing pandemic has not only placed significant strain on healthcare systems and global economies but has also exacerbated psychiatric issues, undermining the mental well-being of countless individuals. It is widely recognized that epidemic events, particularly periods of lockdown, heighten the risk of developing anxiety disorders, depression, and aggressive behaviors.
MATERIALS AND METHODS: In an Italian cohort, a retrospective study was conducted to examine the consumption and costs of antipsychotic medications during and after the Covid-19 pandemic, specifically in the years 2020-2022. Utilizing a database known as the "Sistema Tessere Sanitaria", data on medication dispensations from publicly accessible community pharmacies were extracted, covering a population of approximately one million individuals.
RESULTS: The findings for the years 2020-2021 showed relatively stable patterns, with overall consumption and expenditure slightly decreasing from 2020 to 2021. However, it is worth noting that the antipsychotic drug aripiprazole exhibited an opposite trend, with an increase in consumption. Despite expectations of heightened antipsychotic medication use, real-world evidence indicates a different phenomenon, suggesting that the pandemic might not have significantly influenced the consumption of these medications.
CONCLUSIONS: The limited accessibility to healthcare and medical appointments likely played a role in this observation, potentially masking the therapeutic needs of the population. It will be crucial to monitor the situation in the upcoming years, as normal clinical activities resume, to determine whether there will be an upsurge in the consumption of antipsychotic drugs, which represent a significant portion of the National Healthcare System's expenditure.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Rivista di psichiatria - 58(2023), 5 vom: 18. Sept., Seite 220-225 |
| Sprache: |
Italienisch |
|---|
| Weiterer Titel: |
Distress psicologico durante la pandemia da Covid-19: un’analisi sull’uso di farmaci antipsicotici in un campione di popolazione italiana |
|---|
| Beteiligte Personen: |
Ferrara, Francesco [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.11.2023 Date Revised 01.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1708/4113.41071 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363010572 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363010572 | ||
| 003 | DE-627 | ||
| 005 | 20231226092434.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||ita c | ||
| 024 | 7 | |a 10.1708/4113.41071 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1209.xml |
| 035 | |a (DE-627)NLM363010572 | ||
| 035 | |a (NLM)37807867 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Ferrara, Francesco |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Psychological distress during the Covid-19 pandemic |b an analysis of antipsychotic drug usage patterns in a sample of Italian residents. |
| 246 | 3 | 3 | |a Distress psicologico durante la pandemia da Covid-19: un’analisi sull’uso di farmaci antipsicotici in un campione di popolazione italiana |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2023 | ||
| 500 | |a Date Revised 01.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: The ongoing pandemic has not only placed significant strain on healthcare systems and global economies but has also exacerbated psychiatric issues, undermining the mental well-being of countless individuals. It is widely recognized that epidemic events, particularly periods of lockdown, heighten the risk of developing anxiety disorders, depression, and aggressive behaviors | ||
| 520 | |a MATERIALS AND METHODS: In an Italian cohort, a retrospective study was conducted to examine the consumption and costs of antipsychotic medications during and after the Covid-19 pandemic, specifically in the years 2020-2022. Utilizing a database known as the "Sistema Tessere Sanitaria", data on medication dispensations from publicly accessible community pharmacies were extracted, covering a population of approximately one million individuals | ||
| 520 | |a RESULTS: The findings for the years 2020-2021 showed relatively stable patterns, with overall consumption and expenditure slightly decreasing from 2020 to 2021. However, it is worth noting that the antipsychotic drug aripiprazole exhibited an opposite trend, with an increase in consumption. Despite expectations of heightened antipsychotic medication use, real-world evidence indicates a different phenomenon, suggesting that the pandemic might not have significantly influenced the consumption of these medications | ||
| 520 | |a CONCLUSIONS: The limited accessibility to healthcare and medical appointments likely played a role in this observation, potentially masking the therapeutic needs of the population. It will be crucial to monitor the situation in the upcoming years, as normal clinical activities resume, to determine whether there will be an upsurge in the consumption of antipsychotic drugs, which represent a significant portion of the National Healthcare System's expenditure | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 700 | 1 | |a Trama, Ugo |e verfasserin |4 aut | |
| 700 | 1 | |a Nava, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Langella, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Valentino, Filomena |e verfasserin |4 aut | |
| 700 | 1 | |a Zovi, Andrea |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rivista di psichiatria |d 2009 |g 58(2023), 5 vom: 18. Sept., Seite 220-225 |w (DE-627)NLM194287742 |x 2038-2502 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2023 |g number:5 |g day:18 |g month:09 |g pages:220-225 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1708/4113.41071 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2023 |e 5 |b 18 |c 09 |h 220-225 | ||